Skip to main content
SpringerLink
Log in

At the Extremes of Age: Febrile Neutropenia in Children and Elderly

  • Chapter
  • First Online:
Febrile Neutropenia

  • 1367 Accesses

Abstract

The criteria for diagnosing febrile neutropenia (FN) in children are not different from those used in adults. Slight modifications of the definition—such as the inclusion of a high fever—were not associated with a change of the rate of FN or FN-associated with bacteremia.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Binz P, Bodmer N, Leibundgut K, Teuffel O, Niggli FK, Ammann RA. Different fever definitions and the rate of fever and neutropenia diagnosed in children with cancer: a retrospective two‑center cohort study. Pediatr Blood Cancer. 2012;60:799-805.

    Google Scholar 

  2. Chaudhary N, Kosaraju K, Bhat K, Bairy I, Borker A. Significance of interleukin-6 (IL-6) and C-reactive protein (CRP) in children and young adults with febrile neutropenia during chemotherapy for cancer: a prospective study. J Pediatr Hematol Oncol. 2012;34:617-623.

    Google Scholar 

  3. Rosenblum J, Lin J, Kim M, Levy AS. Repeating blood cultures in neutorpenic children with persistent fevers when the initial blood culture is negative. Pediatr Blood Cancer. 2013;60:923‑927.

    Google Scholar 

  4. Lehrnbecker T, Phillips R, Alexander S, et al; International Pediatric Fever and Neutropenia Guideline Panel. Guideline for the management of fever and neutropenia in children with cancer and/or undergoing hematopietic stem-cell transplantation. J Clin Oncol. 2012;30:4427‑4438.

    Google Scholar 

  5. Gibson F, Chisholm J, Brandford E, et al; CCLG Supportive Care Group. Developing a national ‘low risk’ febrile neutropenia framework for use in children and young people’s cancer care. Support Care Cancer. 2013;5:1241-1251.

    Google Scholar 

  6. Pulsipher MA. Pediatric-specific guidelines for fever and neutropenia: a catalyst for improving care and focusing research. J Clin Oncol. 2012;35:4292-4293.

    Google Scholar 

  7. Exsesmann M. Geriatric oncology: an overview of progresses and challenges. Cancer Res Treat. 2010;42:61-68.

    Google Scholar 

  8. Gillison TL, Chatta GS. Cancer chemotherapy in the elderly patient. Oncology (Williston Park). 2010;24:76-85.

    Google Scholar 

  9. Klastersky J, Gombos A, Georgala A, Awada A. Prevention of neutropenia-related events in elderly patients with hematological cancer. Aging Health. 2011;7:829-842.

    Google Scholar 

  10. Repetto L, Biganzoli L, Koehne CH, et al. EORTC Cancer in the Elderly Task Force guidelines for the use of colony-stimulating factors in elderly patients with cancer. Eur J Cancer. 2003;39:2264-2272.

    Google Scholar 

  11. Aapro MS, Cameron DA, Pessengell R, et al; European Organisation for Research and Treatment of Cancer (EORTC) Granulocyte Colony-Stimulating Factor (G-CSF) Guidelines Working Party. EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours. Eur J Cancer. 2006;42:2433-2453.

    Google Scholar 

  12. Lyman GH, Lyman CH, Agboola O. Risk models for predicting chemotherapy-induced neutropenia. Oncologist. 2005;10:427-437.

    Google Scholar 

  13. Hung A, Mullins CD. Relative effectiveness and safety of chemotherapy in elderly and nonelderly patients with stage III colon cancer: a systematic review. Oncologist. 2013;1:54-63.

    Google Scholar 

  14. Klastersky J, Paesmans M, Rubenstein EB, et al. The multinational Association for Supporting Care in Cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol. 2000;18:3038-3051.

    Google Scholar 

  15. Nørgaard M, Larsson H, Pedersen G, Schønheyder HC, Rothman KJ, Sørensen HT. Short-term mortality of bacteraemia in elderly patients with haematological malignancies. Br J Haematol. 2005;32:25-31.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centre des Tumeurs de l’Universite Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium

    Jean A. Klastersky

Authors
  1. Jean A. Klastersky
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jean A. Klastersky .

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Healthcare

About this chapter

Cite this chapter

Klastersky, J.A. (2014). At the Extremes of Age: Febrile Neutropenia in Children and Elderly. In: Febrile Neutropenia. Springer Healthcare, Tarporley. https://doi.org/10.1007/978-1-907673-70-2_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-907673-70-2_8

  • Published:

  • Publisher Name: Springer Healthcare, Tarporley

  • Print ISBN: 978-1-907673-69-6

  • Online ISBN: 978-1-907673-70-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation